Pfizer – IBM – Collaborate – Internet of Things – 2017
Pfizer & IBM became partners in 2017 “to transform healthcare into the 21st century” by attaching sensors to the body and environment to the “Internet of Things”.
Source: Official Pfizer Video from their #PfizerPartnerships Facebook Page
“We are working with IBM on an effort to transform Parkinson’s care. This collaboration is designed to harness the Internet of Things, monitoring the patient’s health and quality of life in real-time.“~ Pfizer, March 21, 2017
“Imagine a world in which you could measure by watching a person act or move or move through space, or just be themselves as they’re going through their daily life. Imagine if you could capture that information and say “Ok, this tells me the state of health of this patient”. ~ Peter Bergethon, MD, VP of Quantitative Medicine Neuroscience & Pain Research Unit, Pfizer
“… and to do so, you really have to monitor the symptoms that the individual is having pretty much on a continuous basis. Not just episodically, bringing them into the clinic and measuring it once. The problem in the theory of chronic neurological diseases like Parkinson’s, is that the symptoms of the patient experiences, vary minute by minute”. ~ Ajay Royyuru, PhD, Director, Healthcare & Life Sciences, IBM Research
What we’ll do is we’ll basically put a sensor or a series of sensors on the patient or in their environment. The sensors will measure how they move, what their body temperature is, or whether or not they open the refrigerator door. So they’re going to give us information about how the patient is doing, and how they’re interacting with the environment. ~ Pfizer
So, the solution that we’re working on, with Pfizer, is going to take a lot of data continuously from sensors, measurements on the person, measurements in the environment, and actually then, deploy a large body of machine learning algorithms that they have developed and apply here to be able to say which of these symptoms correspond in what manner to what kind of accepted clinical end-points.
Insights from these data points could help the doctor understand and qualify the magnitude of symptoms that the patients is having and in turn, use that information to help tailor the treatment, the dosage, and all other things that are being done to address the symptoms of the patient. ~ IBM
It’s time for medicine to move into the 21st century, and this is the opportunity literally to change the world. The idea that you take a broken body, and you restore it, it just doesn’t get any better than that. ~ Pfizer
Worse, is this particular announcement on the IBM website – April 14, 2022
The International Science Reserve Announces Executive Board and Unveils its First Crisis Activation on Wildfire Prevention and Management
The ISR network unites 1000+ scientists from around the world in a collaborative effort to solve some of the most pressing global challenges with support from New York Academy of Sciences, Google, IBM, Pfizer, UL, Rockfeller Institute, and Grossman’s Department of Population Health
The New York Academy of Sciences (NYAS) and its founding members — including Google, IBM, Pfizer, and UL — today announced the official activation of the International Science Reserve (ISR). Recognizing that our world’s scientific capacity exists across borders, institutions, and sectors, the ISR brings together global scientists across government, academia, and industries to collaborate across geographies and sectors to prepare for and help mitigate potential global crises – from future pandemics to the consequences of climate change.
As part of its ongoing mission, the ISR will facilitate access to specialized scientific and technical resources around the world; conduct scenario planning readiness exercises to increase preparation and anticipation of global impacts, and convene scientists from a wide range of countries to build institutional memory in crisis management and response. This initiative builds on the success of the IBM-led High Performance Computing Consortium (HPCC), which was established in March 2020 in response to the COVID-19 pandemic.
At the helm of the organization is a newly created Executive Board with recognized science leaders from multiple sectors:
- Nicholas Dirks, PhD, President and Chief Executive Officer, New York Academy of Sciences and Co-Chair, ISR Executive Board
- Darío Gil, PhD, Senior Vice President and Director, IBM Research and Co-Chair, ISR Executive Board
- Aida Habtezion, MD, MSc, FRCPC, AGAF, Senior Vice President, Chief Medical Officer, and Head of Worldwide Medical & Safety, Pfizer Inc.
- Philip Nelson, Research Lead, Google
- Robert Slone, PhD, Senior Vice President and Chief Scientist, UL (Former Honeywell)
- Rick Bright, PhD, CEO, Pandemic Prevention Institute and Senior Vice President, The Rockefeller Foundation (Former BARDA director)
- — LISTEN TO HIM with Fauci & Specter in this OCT 2019 video conceptualize an “avian flu virus from china to bypass FDA approval and enforce a UNIVERSAL mRNA FLU VACCINE” 2019 ‘A New Avian Flu Virus From China’ To Enforce “Universal Flu Vaccine” —2 MONTHS BEFORE THE EXACT SCENARIO PLAYED OUT— he is also the one that HCQ was deadly and worked with the FDA to restrict the 63 million doses of HCQ that had been donated to the Strategic National Stockpile – read more about Bright & BARDA on the post: The REAL Anthony Fauci With Robert Kennedy, Jr.
- Lorna Thorpe, PhD, Professor and Director of the Division of Epidemiology, NYU Grossman School of Medicine in the Department of Population Health Grossman School of Medicine, Department of Population Health
The Board will conduct detailed research and analysis to advise on the nature and scope of the crisis area that the ISR will address. When a crisis of transnational scale and sufficient urgency occurs, the Executive Board mobilizes the ISR. Additionally, Mila Rosenthal, PhD, was recently announced as the Executive Director for the ISR.
“Science in the time of crisis is rapid, requiring quick decisions, on the basis of limited information,” says President and CEO of NYAS, Nicholas Dirks. “Scientists should and indeed must play a critical role in the development of effective strategies for responding to crises — from evaluating the multiple effects of different kinds of crises to providing possible solutions and directions for mitigation, immediate and short term as well as long term. We are creating a collaborative entity in the International Science Reserve that will help us to anticipate and prepare for what might be needed to respond to the next global crisis in the best possible way.”
“The world needs the International Science Reserve,” says IBM Senior Vice President and Director of IBM Research, Darío Gil. “Great crises have often been catalysts for institutional innovation in science and technology. The National Science Foundation and the U.S. National Laboratories were created after WWII. NASA and DARPA emerged during the Cold War. Our current crises demand that we innovate again, and this time, an international network of scientists spanning the private sector, academia, non-profits, and government, all united in a commitment to share expertise, prepare, and serve, is the right recipe to address the needs of the world.”
“Pfizer applauds the creation of the International Science Reserve (ISR). The Covid-19 pandemic and climate change have demonstrated the urgent need for crisis-preparedness in the scientific community. We believe that the principles of “science without borders,” “pre-wired circuitry,” and open cross-collaboration will allow scientists to come together, provide innovative solutions and move “at the speed of science,” says Aida Habtezion, Senior Vice President, Chief Medical Officer and Head of Worldwide Medical & Safety, Pfizer Inc. “Pfizer has been at the forefront of the pandemic response, aligning with ISR’s focus on preparing and mobilizing scientists to augment existing response organizations in times of crisis. We are proud to be among the founding partners of this important initiative.”
“The work of the International Science Reserve aligns with UL’s mission of working for a safer world,” says Senior Vice President and Chief Scientist at UL, Robert Slone. “We believe that anticipating and planning for high-risk events such as wildfires, pandemics and electrical grid failures are key to responsible corporate citizenship.”
The structure of the ISR is flexible and able to adapt to needs before, during, and after a complex global crisis. To explore and plan responses to possible crisis scenarios, a widespread network of 1000+ scientists is engaged in the ISR community. In addition to the scientists, executive board and funders, the ISR is building a global network of collaborators and members to augment and accelerate crisis response.
For the first readiness exercise, the ISR has engaged scientists to address the increasing devastating wildfires around the world. Recently, a first-ever United Nations scientific assessment on wildfire risks concluded that crippling wildfires could grow by nearly 60% by the end of this century – largely due to consequences of climate change. In the last two decades, there has been a sharp increase in wildfire season length, wildfire frequency and acreage burned.
The network of scientists directly recruited by the ISR are well-equipped to rise to this challenge due to their deep expertise and knowledge around crisis resolution. As a first test of the operating model of the ISR, the ISR Readiness Exercises for its pilot crisis area, Wildfires, has begun, and the ISR team has been synthesizing findings which will be shared with the scientific community at a later date.
About the International Science Reserve
The International Science Reserve (ISR) is a network of open scientific communities, bringing together specialized resources from across the globe to prepare for and help mitigate complex and urgent global crises. We focus solely on preparing and mobilizing scientists to augment existing response organizations. The New York Academy of Sciences is the coordinating hub of the ISR.
Then there’s this post which has been deleted from the IBM website, but is still accessible on archive.org
“How did a Health Firm get Security Fast for Global Covid-19 Vaccine Trials” – IBM Blog
In this blog, you can learn how Signal Health got security fast for global COVID-19 vaccine trials. Furthermore, I will shortly present the IBM Security MaaS360 with Watson solution.
Signant Health was enlisted as the electronic clinical outcome assessment (eCOA) partner for a global pharmaceuticals Phase III COVID-19 vaccine trials, which involved 30,000+ patients in six countries who spoke 17 languages. Due to the pandemic’s urgency, Signant Health had only days to achieve patient consent, compliance, and engagement through all study-ready mobile devices to complete its mission.
Using IBM Security MaaS360 with Watson, Signant Health had a single platform for patients and study teams to use kiosk mode, which enabled strict controls and security while keeping devices user friendly regardless of location. Additionally, the MaaS360 team delivered request for enhancement (RFE) to continuously support the large-scale device deployments and technical, process and contract issues. IBM MaaS360 helped Signant Health securely deliver vaccine trial results to Pfizer in just five weeks, from patients located everywhere from Argentina to Turkey.
A quick search just now for “Pfizer IBM” also showed the following Pfizer-IBM Press Releases & News:
- 13 Apr 2016 – Pfizer and IBM join forces to develop remote monitoring solutions “Using an experimental Internet of Things system that enables remote monitoring, the companies believe the multi-year project has the potential to change the way clinical trials are conducted.”
- 1 Dec 2016 – IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery
- IBM have removed the Pfizer tag from their blog
- IBM Watson Health and Pfizer Collaborating to Accelerate Immuno-oncology Research
- 11 Apr 2017 – Pfizer and IBM Working to Transform Parkinson’s Disease Care – Pfizer YouTube “Pfizer and IBM leaders discuss their collaboration to develop remote monitoring solutions that aim to transform Parkinson’s disease care. BlueSky configures wearable devices to recognize the activities of daily living, creating a unique technology scalable across all fields of medicine.”
- 22 Oct 2022 – IBM and Pfizer Believe Machine Learning Can Predict Alzheimer’s Risk “Researchers with Pfizer and IBM developed an artificial intelligence (AI) model that they claim can predict the eventual onset of Alzheimer’s disease with 71% accuracy based on a language sample. They published the research today in The Lancet eClinicalMedicine.” (01)
Browse: Pfizer | Rigged Agenda | What’s in the Vials? | Graphene | 5G
Posts tagged “Digital ID“
- IMF wants to use Internet History for Credit Score
- Climate Science Q&A (Texti vs ChatGPT AI)
- Debating fake AI bots about Australian Politicians
- Decentralization & Digital Enslavement (chat with AI bots)
- [Prof Nazar] C19 Vaccine-Bioweapon Genocide (paper & presentation)
- Elon Musk – Golden Share – Something to explore
- Transhumanism, CBDCs, Nano-Network C19 Shots & the coming Social Credit System
- CBDC – Central Bank Digital Currency
- C19 Vial Contents Summary (Presentation & Paper comparing 26 Labs from 16 countries)
- “Voice in your head” military weapon only you can hear & other mass-mind-control methods since the 1940s
- The Director ID in Australia is Illegal
- Sberbank Owns All Aspects of Russian Lives
- Archbishop Viganò Addresses Australia [27 Feb 2022]
- Dr Robert Malone on who controls the world
- “The Playbook” – how the few control the many [Covid Edition]
- G20 “Let’s get Digital Health Pass for Next Pandemic to Restrict Movement” | Nov 2022
- Digital ID = Permanent Enslavement – Australia & World – WAKE UP!!!
- Convenient Deaths or Arrests (Whistleblowers)
- Mark of the Beast theory – Summary of Evidence
- Carla Mardell | How to run a fear-based Health campaign in Australia
I just joined Gettr and I highly recommend it - it's the best alternative to them all so far:
Telegram Channels: Get Post Updates | Chat/Comment | Video Evidence | c19 Images/Memes
|01||Eyigoz E, Mathur S, Santamaria M, Cecchi G, Naylor M. Linguistic markers predict onset of Alzheimer’s disease. EClinicalMedicine. 2020 Oct 22;28:100583. doi: 10.1016/j.eclinm.2020.100583. PMID: 33294808; PMCID: PMC7700896.|